Search Results - "PRIOLO, Carmen"
-
1
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer
Published in Cancer research (Chicago, Ill.) (15-12-2014)“…Cancer cells may overcome growth factor dependence by deregulating oncogenic and/or tumor-suppressor pathways that affect their metabolism, or by activating…”
Get full text
Journal Article -
2
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Published in EMBO molecular medicine (01-04-2014)“…5′AMP‐activated kinase (AMPK) constitutes a hub for cellular metabolic and growth control, thus representing an ideal therapeutic target for prostate cancers…”
Get full text
Journal Article -
3
Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma
Published in Proceedings of the National Academy of Sciences - PNAS (03-07-2018)“…Chromophobe renal cell carcinoma (ChRCC) accounts for 5% of all sporadic renal cancers and can also occur in genetic syndromes including Birt–Hogg–Dube (BHD)…”
Get full text
Journal Article -
4
New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK
Published in Clinical cancer research (01-07-2010)“…Although the role of metabolic syndrome (MS) and a high fat diet in prostate cancer (PCa) risk is still a matter of intense debate, it is becoming increasingly…”
Get full text
Journal Article -
5
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Published in JNCI : Journal of the National Cancer Institute (01-04-2009)“…Background Overexpression of the fatty acid synthase (FASN) gene has been implicated in prostate carcinogenesis. We sought to directly assess the oncogenic…”
Get full text
Journal Article -
6
Plasma metabolomics and clinical predictors of survival differences in COPD patients
Published in Respiratory research (15-10-2019)“…Plasma metabolomics profile (PMP) in COPD has been associated with clinical characteristics, but PMP's relationship to survival has not been reported. We…”
Get full text
Journal Article -
7
Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells
Published in The Journal of experimental medicine (13-01-2014)“…Lymphangioleiomyomatosis (LAM) is a progressive neoplastic disorder that leads to lung destruction and respiratory failure primarily in women. LAM is typically…”
Get full text
Journal Article -
8
Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways
Published in PloS one (09-04-2019)“…Lymphatic vessels play an important role in health and in disease. In this study, we evaluated the effects of GSK3-β inhibition on lung lymphatic endothelial…”
Get full text
Journal Article -
9
Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis
Published in American journal of respiratory cell and molecular biology (01-07-2015)“…Lymphangioleiomyomatosis (LAM) is a destructive lung disease affecting women. LAM is caused by mutations in the tuberous sclerosis complex (TSC) genes. The TSC…”
Get full text
Journal Article -
10
MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM)
Published in PloS one (29-03-2013)“…Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of smooth muscle-like cells in the lung resulting in cystic…”
Get full text
Journal Article -
11
The isopeptidase USP2a protects human prostate cancer from apoptosis
Published in Cancer research (Chicago, Ill.) (01-09-2006)“…Deubiquitinating enzymes can prevent the destruction of protein substrates prior to proteasomal degradation. The ubiquitin-specific protease 2a (USP2a)…”
Get full text
Journal Article -
12
Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors
Published in The American journal of pathology (01-04-2010)“…Serum prostate-specific antigen screening has led to earlier detection and surgical treatment of prostate cancer, favoring an increasing incidence-to-mortality…”
Get full text
Journal Article -
13
FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma
Published in Clinical cancer research (01-06-2009)“…Purpose: FOXA1 is a mammalian endodermal transcription factor belonging to the human forkhead box gene family that plays a role in certain tumor types. Here,…”
Get full text
Journal Article -
14
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Published in EMBO molecular medicine (01-10-2014)Get full text
Journal Article -
15
Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment
Published in JNCI : Journal of the National Cancer Institute (01-08-2014)“…Myopericytoma (MPC) is a rare tumor with perivascular proliferation of pluripotent stem-cell-like pericytes. Although indolent, MPC may be locally aggressive…”
Get full text
Journal Article -
16
Epithelial-Restricted Gene Profile of Primary Cultures from Human Prostate Tumors: A Molecular Approach to Predict Clinical Behavior of Prostate Cancer
Published in Molecular cancer research (01-02-2006)“…The histopathologic and molecular heterogeneity of prostate cancer and the limited availability of human tumor tissue make unraveling the mechanisms of…”
Get full text
Journal Article -
17
B-RafV600E and thrombospondin-1 promote thyroid cancer progression
Published in Proceedings of the National Academy of Sciences - PNAS (08-06-2010)“…Although B-Raf V600E is the most common somatic mutation in papillary thyroid carcinoma (PTC), how it induces tumor aggressiveness is not fully understood…”
Get full text
Journal Article -
18
Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism
Published in Circulation research (25-06-2021)“…[Figure: see text]…”
Get full text
Journal Article -
19
52 Ferroptosis Suppressor Protein 1 is a Potent and Targetable Inhibitor of Ferroptosis in Chromophobe Renal Cell
Published in The oncologist (Dayton, Ohio) (06-08-2024)“…Abstract Background There are currently no proven therapies for metastatic or unresectable Chromophobe renal cell carcinoma (ChRCC). Ferroptosis is an…”
Get full text
Journal Article -
20
Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift
Published in Molecular cancer research (01-01-2015)“…mTORC1 is an established master regulator of cellular metabolic homeostasis, via multiple mechanisms that include altered glucose and glutamine metabolism, and…”
Get full text
Journal Article